O., Thulesius, H
The Gut-Brain Connection Matters GLP-1 medications do not only work in the stomach
RETA treatment improved metabolic factors, boosted anti-tumor immunity, and potently blunted tumor progression in non-obesity associated lung adenocarcinoma Based on the dramatic findings in PDAC, an obesity-associated cancer, we were interested in whether RETA could also be effective in a non-obesity associated cancer
Search ClinicalTrials.gov for retatrutide Canada to find studies with Canadian sites
Less common but more serious risks include: Pancreatitis, which can cause severe abdominal pain and may require stopping the medication Gallbladder problems, such as gallstones or inflammation, especially with higher doses or longer use Allergic reactions, including swelling or difficulty breathing, which need immediate medical attention Injection site reactions, such as redness or itching, with injectable forms Rare vision changes or worsening diabetic eye disease, especially when blood sugar improves rapidly Anyone with intense abdominal pain, signs of dehydration (such as dizziness or reduced urination), or unexpected vision changes should seek medical advice promptly
Weight loss can increase testosterone sensitivity, potentially requiring dose adjustments in your replacement therapy